FMR CORP 13D and 13G filings for :
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-12 09:22 am Purchase |
2024-12-31 | 13G | Teva Pharmaceutical Industries Limited TEVA |
FMR CORP | 81,983,229 7.200% |
19,242,467![]() (+30.67%) |
Filing |
2024-11-12 10:34 am Purchase |
2024-11-08 | 13G | Teva Pharmaceutical Industries Limited TEVA |
FMR CORP | 62,740,762 5.537% |
33,877,274![]() (+117.37%) |
Filing |